Medika d.d Valuation

Is MDKA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MDKA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MDKA (€5650) is trading below our estimate of fair value (€15698.7)

Significantly Below Fair Value: MDKA is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MDKA?

Key metric: As MDKA is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for MDKA. This is calculated by dividing MDKA's market cap by their current earnings.
What is MDKA's PE Ratio?
PE Ratio	8.1x
Earnings	€20.23m
Market Cap	€165.04m

MDKA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.3x
Enterprise Value/EBITDA	8.9x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does MDKA's PE Ratio compare to its peers?

The above table shows the PE ratio for MDKA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	16.1x
9527 Alf Meem Yaa for Medical Supplies and Equipment	18.2x	n/a	ر.س690.9m
PFRM3 Profarma Distribuidora de Produtos Farmacêuticos	8x	n/a	R$858.3m
2393 Nippon Care Supply	17.8x	n/a	JP¥29.7b
4164 CHC Healthcare Group	20.5x	68.3%	NT$6.6b
MDKA Medika d.d	8.1x	n/a	€165.0m

Price-To-Earnings vs Peers: MDKA is good value based on its Price-To-Earnings Ratio (8.1x) compared to the peer average (16.1x).

Price to Earnings Ratio vs Industry

How does MDKA's PE Ratio compare vs other companies in the European Healthcare Industry?

2 Companies	Price / Earnings	Estimated Growth	Market Cap

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: MDKA is good value based on its Price-To-Earnings Ratio (8.1x) compared to the European Healthcare industry average (18.2x).

Price to Earnings Ratio vs Fair Ratio

What is MDKA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MDKA PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	8.1x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate MDKA's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.